Related references
Note: Only part of the references are listed.Differential Characteristics of HMGB2 Versus HMGB1 and their Perspectives in Ovary and Prostate Cancer
Maria Camara-Quilez et al.
CURRENT MEDICINAL CHEMISTRY (2020)
A panel of autoantibodies against tumor-associated antigens in the early immunodiagnosis of lung cancer
Di Jiang et al.
IMMUNOBIOLOGY (2020)
Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer
Jian Fang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
LncRNA SNHG5 promotes nasopharyngeal carcinoma progression by regulating miR-1179/HMGB3 axis
Dengtao Liu et al.
BMC CANCER (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer
Tingting Wang et al.
CLINICAL IMMUNOLOGY (2020)
The interplay between HIF-1α and noncoding RNAs in cancer
Xiafeng Peng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update
Joseph A. Clara et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Involvement of Intracellular and Extracellular High-Mobility Group Box-1 in the Progression of Esophageal Squamous Cell Carcinoma
Daiki Matsubara et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway
Xiaofei Song et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
Targeting Chromosomal Architectural HMGB Proteins Could Be the Next Frontier in Cancer Therapy
Anirban Mukherjee et al.
CANCER RESEARCH (2020)
The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1? in liver cancer cells
Changying Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Targeting Inflammation Driven by HMGB1
Huan Yang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Targeting the beta-catenin signaling for cancer therapy
Xue Zhang et al.
PHARMACOLOGICAL RESEARCH (2020)
HMGB1 release promotes paclitaxel resistance in castration-resistant prostate cancer cells via activating c-Myc expression
Xiu Lei et al.
CELLULAR SIGNALLING (2020)
Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells
Eric Flores-Hernandez et al.
CELLULAR SIGNALLING (2020)
CircEPSTI1 Promotes the Progression of Non-Small Cell Lung Cancer Through miR-145/HMGB3 Axis
Yuanyuan Xie et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results
Yam Nath Paudel et al.
PHARMACOLOGICAL RESEARCH (2020)
MiR-200b in heme oxygenase-1-modified bone marrow mesenchymal stem cell-derived exosomes alleviates inflammatory injury of intestinal epithelial cells by targeting high mobility group box 3
Dong Sun et al.
CELL DEATH & DISEASE (2020)
CircMMP1promotes the progression of glioma throughmiR-433/HMGB3axis in vitro and in vivo
Kai Yin et al.
IUBMB LIFE (2020)
Hmgb3 Induces the Differentiation of Uterine Stromal Cells Through Targeting Ptn
Kai Wang et al.
REPRODUCTIVE SCIENCES (2019)
Downregulation of microRNA-532-5p promotes the proliferation and invasion of bladder cancer cells through promotion of HMGB3/Wnt/β-catenin signaling
Xiaojuan Xie et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2019)
Down-regulated expressed protein HMGB3 inhibits proliferation and migration, promotes apoptosis in the placentas of fetal growth restriction
Yan Lv et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
Proteomic Strategy for Identification of Proteins Responding to Cisplatin-Damaged DNA
Wenjuan Zeng et al.
ANALYTICAL CHEMISTRY (2019)
Targeting the High-Mobility Group Box 3 Protein Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
Anirban Mukherjee et al.
CANCER RESEARCH (2019)
HMGB3 silence inhibits breast cancer cell proliferation and tumor growth by interacting with hypoxia-inducible factor 1α
Jun Gu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
High-mobility group box 2 promoted proliferation of cervical cancer cells by activating AKT signaling pathway
Pengnan Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
MicroRNA-329 upregulation impairs the HMGB2/β-catenin pathway and regulates cell biological behaviors in melanoma
You Mo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses
Pooja Mandke et al.
DNA REPAIR (2019)
Long non-coding RNA HOTTIP promotes hypoxia-induced glycolysis through targeting miR-615-3p/HMGB3 axis in non-small cell lung cancer cells
Jiang Shi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells
Martin Kucirek et al.
FASEB JOURNAL (2019)
Effects of microRNA-513b on cell proliferation, apoptosis, invasion, and migration by targeting HMGB3 through regulation of mTOR signaling pathway in non-small-cell lung cancer
Jiying Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
High Mobility Group Box-1 and Diabetes Mellitus Complications: State of the Art and Future Perspectives
Federico Biscetti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1/VEGF-D signaling
Wei Da et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2019)
Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis
Yasutaka Yamada et al.
JOURNAL OF HUMAN GENETICS (2018)
HMGB2 is a novel adipogenic factor that regulates ectopic fat infiltration in skeletal muscles
Deokcheol Lee et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
HMGB3 promotes the proliferation and metastasis of glioblastoma and is negatively regulated by miR-200b-3p and miR-200c-3p
Jianxun Liu et al.
CELL BIOCHEMISTRY AND FUNCTION (2018)
Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes
Wen-Jie Zheng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma
Wenjie Zheng et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein
Long-kun Wang et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)
Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity
Samuel G. Awuah et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
HMGB3 modulates ROS production via activating TLR cascade in Apostichopus japonicus
Zhimeng Lv et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2017)
High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progression
Hye Won Chung et al.
CANCER SCIENCE (2017)
Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer
Xin Cai et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2017)
MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3
Xiunan Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
IL-1β/HMGB1 signalling promotes the inflammatory cytokines release via TLR signalling in human intervertebral disc cells
Fang Fang et al.
BIOSCIENCE REPORTS (2016)
The HMGB1 C-Terminal Tail Regulates DNA Bending
Rebecca H. Blair et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
HMGB4 is expressed by neuronal cells and affects the expression of genes involved in neural differentiation
Ari Rouhiainen et al.
SCIENTIFIC REPORTS (2016)
Knockdown of High Mobility Group-Box 3 (HMGB3) Expression Inhibits Proliferation, Reduces Migration, and Affects Chemosensitivity in Gastric Cancer Cells
Shengnan Guo et al.
MEDICAL SCIENCE MONITOR (2016)
High mobility group (HMG) proteins: Modulators of chromatin structure and DNA repair in mammalian cells
Raymond Reeves
DNA REPAIR (2015)
Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2
Qiu-Yu Zhang et al.
ONCOLOGY REPORTS (2015)
Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients
Minghui Li et al.
TUMOR BIOLOGY (2015)
Two high-mobility group box domains act together to underwind and kink DNA
R. Sanchez-Giraldo et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2015)
Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-.B pathway in vitro and in vivo
Jing Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Upregulation of miR-513b inhibits cell proliferation, migration, and promotes apoptosis by targeting high mobility group-box 3 protein in gastric cancer
Xudong Chen et al.
TUMOR BIOLOGY (2014)
High-mobility group box 2 (HMGB2) modulates radioresponse and is downregulated by p53 in colorectal cancer cell
Young-Joo Shin et al.
CANCER BIOLOGY & THERAPY (2013)
HMGB3 characterization in gastric cancer
Y. Gong et al.
GENETICS AND MOLECULAR RESEARCH (2013)
Tumor Suppressive Function of mir-205 in Breast Cancer Is Linked to HMGB3 Regulation
Ola A. Elgamal et al.
PLOS ONE (2013)
Prognostic value of HMGB3 expression in patients with non-small cell lung cancer
Ning Song et al.
TUMOR BIOLOGY (2013)
High-Mobility Group Boxes Mediate Cell Proliferation and Radiosensitivity via Retinoblastoma-Interaction-Dependent and -Independent Mechanisms
Li-Li Wang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
HMGB1-Facilitated p53 DNA Binding Occurs via HMG-Box/p53 Transactivation Domain Interaction, Regulated by the Acidic Tail
John P. Rowell et al.
STRUCTURE (2012)
High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma
Hua-Rong Tang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Suppression of immune responses by nonimmunogenic oligodeoxynucleotides with high affinity for high-mobility group box proteins (HMGBs)
Hideyuki Yanai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Nuclear functions of the HMG proteins
Raymond Reeves
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
HMGB proteins: Interactions with DNA and chromatin
Michal Stros
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype
F. J. T. Staal et al.
LEUKEMIA (2010)
HMGB4, a Novel Member of the HMGB Family, Is Preferentially Expressed in the Mouse Testis and Localizes to the Basal Pole of Elongating Spermatids
Raffaella Catena et al.
BIOLOGY OF REPRODUCTION (2009)
Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem Cells
Tim C. P. Somervaille et al.
CELL STEM CELL (2009)
Photoaffinity Isolation and Identification of Proteins in Cancer Cell Extracts that Bind to Platinum-Modified DNA
Evan R. Guggenheim et al.
CHEMBIOCHEM (2009)
Nucleotide excision repair pathway review I: Implications in ovarian cancer and platinum sensitivity
J. Salvador Saldivar et al.
GYNECOLOGIC ONCOLOGY (2007)
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation
John D. Gordan et al.
CANCER CELL (2007)
Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation
Michael J. Nemeth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Hmgb3 deficiency deregulates proliferation and differentiation of con-m-ion lymphoid and myeloid progenitors
MJ Nemeth et al.
BLOOD (2005)
Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function
S Müller et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation
MJ Nemeth et al.
BLOOD (2003)
Efficient specific DNA binding by p53 requires both its central and C-terminal domains as revealed by studies with high-mobility group 1 protein
K McKinney et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
HMG1 and 2, and related 'architectural' DNA-binding proteins
JO Thomas et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
The effect of the acidic tail on the DNA-binding properties of the HMG1,2 class of proteins: Insights from tail switching and tail removal
KB Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Share Paper
